Just 10 drugs accounted for 63 percent of the wasted money, as reported by Axios.
Velcade, a chemotherapy drug designed to treat myeloma and mantle cell lymphoma made by Takeda Pharmaceutical, was the most wasted drug, costing Medicare $123 million.
NPlate, a bone marrow stimulant made by Amgen, cost Medicare $78 million.
Find the full data here.
More articles on pharmacy:
Novo Nordisk selling authorized generics of insulin at 50% discount
New Year’s Day drug price hikes hit more than 250 meds
Aurobindo Pharma recalls antidepressant with mislabeled dosage
